These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 20796232

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of an oral bisphosphonate and three intravenous bisphosphonates on several cell types in vitro.
    Jung J, Park JS, Righesso L, Pabst AM, Al-Nawas B, Kwon YD, Walter C.
    Clin Oral Investig; 2018 Sep; 22(7):2527-2534. PubMed ID: 29388023
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Geranyl-geraniol addition affects potency of bisphosphonates-a comparison in vitro promising a therapeutic approach for bisphosphonate-associated osteonecrosis of the jaw and oral wound healing.
    Otto M, Lux C, Schlittenbauer T, Halling F, Ziebart T.
    Oral Maxillofac Surg; 2022 Jun; 26(2):321-332. PubMed ID: 34392434
    [Abstract] [Full Text] [Related]

  • 8. Zoledronate, ibandronate and clodronate enhance osteoblast differentiation in a dose dependent manner--a quantitative in vitro gene expression analysis of Dlx5, Runx2, OCN, MSX1 and MSX2.
    Koch FP, Merkel C, Al-Nawas B, Smeets R, Ziebart T, Walter C, Wagner W.
    J Craniomaxillofac Surg; 2011 Dec; 39(8):562-9. PubMed ID: 21030265
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Bisphosphonates inhibit cell functions of HUVECs, fibroblasts and osteogenic cells via inhibition of protein geranylgeranylation.
    Hagelauer N, Ziebart T, Pabst AM, Walter C.
    Clin Oral Investig; 2015 Jun; 19(5):1079-91. PubMed ID: 25261400
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Novel therapy to reverse the cellular effects of bisphosphonates on primary human oral fibroblasts.
    Cozin M, Pinker BM, Solemani K, Zuniga JM, Dadaian SC, Cremers S, Landesberg R, Raghavan S.
    J Oral Maxillofac Surg; 2011 Oct; 69(10):2564-78. PubMed ID: 21807448
    [Abstract] [Full Text] [Related]

  • 16. Osteonecrosis of the jaw: effect of bisphosphonate type, local concentration, and acidic milieu on the pathomechanism.
    Otto S, Pautke C, Opelz C, Westphal I, Drosse I, Schwager J, Bauss F, Ehrenfeld M, Schieker M.
    J Oral Maxillofac Surg; 2010 Nov; 68(11):2837-45. PubMed ID: 20971371
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mechanical loading influences the effects of bisphosphonates on human periodontal ligament fibroblasts.
    Jacobs C, Walter C, Ziebart T, Dirks I, Schramm S, Grimm S, Krieger E, Wehrbein H.
    Clin Oral Investig; 2015 Apr; 19(3):699-708. PubMed ID: 25055746
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of bisphosphonates on macrophagic THP-1 cell survival in bisphosphonate-related osteonecrosis of the jaw (BRONJ).
    Hoefert S, Sade Hoefert C, Munz A, Schmitz I, Grimm M, Yuan A, Northoff H, Reinert S, Alexander D.
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Mar; 121(3):222-32. PubMed ID: 26725718
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.